Vimarsana
Biggest News Aggregation in the World

Yang Jiang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Yang Jiang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Yang Jiang Today - Breaking & Trending Today

The Daredevil Insula: Thrill-Seeking Behavior Based In The Brain? - Vimarsana News

The Daredevil Insula: Thrill-Seeking Behavior Based In The Brain?

Sky diving and base jumping are not for everyone. However, for certain people, the more risk and adrenaline involved in an activity, the better! What draws some people to daredevil behavior while others shy away from it? Psychologists Jane E. Joseph, Xun Liu, Yang Jiang and Thomas H.

3 UK students awarded 2024-25 Goldwater Scholarship - Vimarsana News

3 UK students awarded 2024-25 Goldwater Scholarship

The Barry M. Goldwater Scholarship is one of the most prestigious national undergraduate scholarships in the natural sciences, engineering and mathematics.

Source: uky.edu
China's youth compete for stable gov't jobs in unstable economic times | Business and Economy News - Vimarsana News

China's youth compete for stable gov't jobs in unstable economic times | Business and Economy News

The number of candidates taking China’s civil service exam reaches a record high as graduates seek secure jobs.

Crumbling buildings and broken dreams: China's unfinished homes | Infographic - Vimarsana News

Crumbling buildings and broken dreams: China's unfinished homes | Infographic

Tens of millions of homes lie vacant across China following the country’s credit-fuelled construction boom.

uniQure Announces Major Presence at the European Society of Gene and Cell Therapy (ESGCT) Annual Meeting - uniQure (NASDAQ:QURE) - Vimarsana News

uniQure Announces Major Presence at the European Society of Gene and Cell Therapy (ESGCT) Annual Meeting - uniQure (NASDAQ:QURE)

LEXINGTON, Mass. and AMSTERDAM, Oct. 24, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced